Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-29 @ 5:42 PM
Study NCT ID:
NCT05735392
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2023-01-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)
Sponsor:
Consorzio Oncotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-31
First Submit QC Date:
None
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-09
Last Update Post Date:
2023-02-21
Last Update Post Date Type:
ACTUAL